Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Investigation of the Effect of Lipikar Baume AP+M [NA]

View source ↗

Summary

A clinical trial is investigating Lipikar Baume AP+M for actinic keratoses. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipikar Baume AP+M (emollient moisturizer)

Snippet

Sponsor: CentroDerm GmbH | Conditions: Actinic Keratoses | NA | Status: RECRUITING